Urokinase
Therapeutic Group
Anti-thrombotic AgentsIndication Dosage
Urokinase is a medication used to dissolve blood clots in the body. It's often prescribed when someone has a clot that needs to be broken up to prevent serious health problems like heart attacks or strokes.
Deep-vein Thrombosis (thromboembolic Occlusive Vascular Disease):
- Adult: Initially 4400 Units/kg, Over 10 Minutes, In 15ml Sodium Chloride 0.9%, Followed By 4400 Units/kg/hr For 12-24 Hrs.
Pulmonary Embolism (thromboembolic Occlusive Vascular Disease):
- Adult: Initially 4400 Units/kg, Over 10 Minutes, In 15ml Sodium Chloride 0.9%, Followed By (by IV infusion) 4400 Mcg/kg/hr For 12 Hrs, Alternatively (by Intra-arterial Injection) Initially 15000 Units/kg, To Be Injected Into Pulmonary Artery, Subsequent Doses Adjusted According To Response; Maximum 3 Doses Per Day
Occlusive Peripheral Arterial Disease:
By Intra-arterial Infusion:
- Adult: Consult Product Literature
Occluded Intravenous Catheters And Cannulas (blocked By Fibrin Clots):
By Intra-arterial Or IV Inj:
- Adult: 5000-25 000 Units, To Be Injected Directly Into a Catheter Or Cannula, Dissolved In Sodium Chloride 0.9% To Fill The Catheter Or Cannula Lumen; Leave For 20-60 Min Then Aspirate The Lysate; Repeat If Necessary.
Content
- Inj: Per Vial: Urokinase 25,000 /50,000 Units; Powder For Reconstitution.
Pregnancy
Contraindicated
Stability
- Fibrinolytic
- Antithrombotic Drugs; Tissue Plasminogen Activators
Contra Indications
- Recent Bleeding Following Surgery, Cerebrovascular Bleeding, Severe Hypertension.
Precautions
- Recent Bleeding Following Surgery, Cerebrovascular Bleeding, Severe Hypertension.
Lactation
- Caution Advised
Side Effects
- Local Irritation
- Bleeding And Haemorrhagic Complications
- Pyrexia
- Haematuria
- Embolic Episodes
- Cholesterol Embolism
- Allergic Reactions.